COMMUNIQUÉS West-GlobeNewswire

Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome
09/07/2018
Study will Evaluate the Efficacy and Safety of Transdermally-Delivered Cannabidiol (CBD) in Children and Adolescents with Fragile X Syndrome Top Line Results Expected in Second Half of 2019 Zynerba to host conference [...]
TRU NIAGEN® to be featured at the American Association of Naturopathic Physicians Annual Convention and the 2018 Healthy Aging Summit
09/07/2018
Participation at two mid-July events will target healthcare practitioners IRVINE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to [...]
Athenex Names Timothy Cook as Senior Vice President of Global Commercial Oncology
09/07/2018
Mr. Cook was Previously VP and Chief Operating Officer of Oncology at Lilly BUFFALO, N.Y., July 09, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, [...]
Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc.
09/07/2018
RANCHO CUCAMONGA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals Inc. (“ANP”). To date, [...]
Novo Nordisk A/S - Share repurchase programme
09/07/2018
Bagsværd, Denmark, 9 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
New legal entity for LIDDS license partner in China
09/07/2018
LIDDS has agreed to transfer the licensing agreement for Liproca® Depot in China to Jiangxi Puheng Pharmaceuticals Ltd following a request from the owners of Jiangsu Ambition Medical. The change of legal entity will not [...]
Shire plc : Rule 2.9 Announcement
09/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 July 2018 Shire [...]
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
09/07/2018
Mechelen, Belgium; 9 July 2018; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces the PINTA Phase 2 trial design with its GPR84 inhibitor GLPG1205 in patients with idiopathic pulmonary fibrosis (IPF). [...]
Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial
09/07/2018
Benefit Observed at 12 months Postoperatively Following Single Administration SAN DIEGO, July 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) announced publication in the peer-reviewed journal, [...]
Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma
09/07/2018
License grants Axovant worldwide rights to AXO-AAV-OPMD utilizing proprietary Silence-and-Replace technology, which suppresses mutant protein production while restoring expression of functional protein Plan to initiate [...]
National Lipid Association Announces Recipients of 2018-19 Junior Faculty Research Awards
06/07/2018
Nathan O. Stitziel, M.D., Ph.D., Soumik BasuRay, Ph.D., each earn two-year grant for lipid disorder research JACKSONVILLE, Fla., July 06, 2018 (GLOBE NEWSWIRE) -- The National Lipid Association announced on Friday the [...]
John Inadomi, MD is Honored by the American Health Council for “Best in Medicine”
06/07/2018
NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud to honor John Inadomi, MD as “America’s Best Doctor” for his contributions to the gastrointestinal field. Currently a professor of [...]
Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification
06/07/2018
DANVERS, Mass., July 06, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ:ABMD) announced that on Thursday, July 26, 2018, the Company will release financial results for the first quarter of fiscal 2019. The Company will [...]
Barbara Nye, MD is Appointed to the American Health Council’s Board of Physicians
06/07/2018
NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- The American Health Council proudly appointed Barbara Nye, MD to its Board of Physicians for her outstanding contributions to the medical field. Currently serving as co- [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2018
06/07/2018
Communiqué de presse Villepinte, le 6 juillet 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Tauriga Sciences Inc. Receives Confirmation from FINRA that its Reverse Split will take Effect at Open of Trading Monday July 9, 2018; the Company’s Ticker Symbol will be Amended to “TAUGD” for a Period of 20 Business Days
06/07/2018
NEW YORK, NY, July 06, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (OTC PINK: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
AC Immune Announces Results of Annual General Meeting
06/07/2018
Lausanne, Switzerland, July 6, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that the shareholders of the Company have [...]
Major shareholder announcement
06/07/2018
Orphazyme A/S Company announcement No. 09/2018 Company Registration No. 32266355 Copenhagen, July 6, 2018 – Orphazyme A/S (the “ Company ”), a biopharmaceutical company dedicated to developing treatments for patients [...]
Auxly Announces Upgrade on OTC Markets to OTCQX
06/07/2018
VANCOUVER, British Columbia, July 06, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that effective today, July 6, 2018, the Company's common shares [...]

Pages